JEFFREY S MATHIESEN
CIK 1296853 · CFO and Treasurer · last filed 2026-04-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$43.5K
Companies
5
Total Filings
51
Lifetime Open-Market Net
$55.9K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NMTC | Director | 26,057 | $1.67 | $43.5K | $0 | 6 | 2026-04-07 |
| HSDT | CFO and Treasurer | 0 | $1.69 | $0 | $15.9K | 10 | 2025-07-03 |
| Panbela Therapeutics, Inc. (PBLA) Delisted | Director | 0 | $0.01 | $0 | $0 | 3 | 2023-03-29 |
| HCTI | Director | — | $1.63 | — | $0 | 1 | 2022-08-22 |
| MetaVia Inc. (GEMP) Delisted | Chief Financial Officer | 565 | — | — | $40.0K | 6 | 2018-01-30 |
Recent Filings · Page 2 of 6
51 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-08-22 | HCTI | — | — | $0 | EDGAR |
| 2022-06-02 | NMTC | Grant (A) | +29,240 | $0 | EDGAR |
| 2022-05-25 | HSDT | Grant (A) | — | $0 | EDGAR |
| 2022-02-18 | HSDT | Grant (A) | +8,011 | $0 | EDGAR |
| 2021-12-20 | HSDT | Buy (P) | +3,000 | $15.9K | EDGAR |
| 2021-06-15 | HSDT | Grant (A) | — | $0 | EDGAR |
| 2021-06-04 | NMTC | Grant (A) | +4,592 | $0 | EDGAR |
| 2021-05-27 | HSDT | Grant (A) | +937 | $0 | EDGAR |
| 2021-05-27 | Panbela Therapeutics, Inc. (PBLA) Delisted | Grant (A) | +4,316 | $0 | EDGAR |
| 2020-12-03 | Panbela Therapeutics, Inc. (PBLA) Delisted | Grant (A) | +2,875 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.